Large pharma drug licensing from China reaches record high at 28 per cent in 2024, reveals GlobalData Read more
Cadila Pharmaceuticals launches Vasograin EC with US FDA-approved formulation for migraine relief Read more
Novo Nordisk reports SOUL trial results showing reduced cardiovascular risk with oral semaglutide in type 2 diabetes Read more
Asahi Kasei establishes life science division to streamline bioprocess operations for pharma sector Read more